NCT04010435

Brief Summary

Vestibular disorders are disabling conditions that can have a major effect on functioning especially on daily activities and social participation. Latest epidemiological studies estimate that as many as 35% of adults aged 40 years or older had experienced some form of vestibular dysfunction. Non invasive brain stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS) have been investigated as therapeutic interventions for various neurological disorders like motor deficits and balance disorders after various neurological deficits. The purpose of this study is to compare between rTMs stimulation and galvanic vestibular stimulation in patients with unilateral peripheral vestibular disorders.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 8, 2019

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

February 14, 2024

Status Verified

February 1, 2024

Enrollment Period

5.9 years

First QC Date

July 3, 2019

Last Update Submit

February 12, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Vestibular canal weakness

    Videonystagmography- Scores ranging zero min score and 100 max score

    1 mounth

  • Dizziness handicapped inventory

    identify difficulties that you may be experiencing because of your dizziness- 25 items with max score 100 and min score zero

    1 month

Secondary Outcomes (3)

  • Postural stability

    1 month

  • Balance

    1 month

  • Vestibular disorders activities of daily living

    1 month

Study Arms (3)

Group A (r TMS group)

ACTIVE COMPARATOR

Twenty randomly assigned patients with unilateral peripheral vestibular disorders will undergo 10 Hz rTMS to the dorsolateral prefrontal cortex of their dominant hemisphere; in addition to designed vestibular rehabilitation exercises.

Device: repetitive transcranial magnetic stimulation

Group B (Galvanic stimulation)

ACTIVE COMPARATOR

Twenty randomly assigned patients with unilateral peripheral vestibular disorders will undergo galvanic vestibular stimulation; in addition to designed vestibular rehabilitation exercises.

Device: Galvanic stimulation

Control (Group C)

NO INTERVENTION

Twenty randomly assigned patients with unilateral peripheral vestibular disorders will undergo designed vestibular rehabilitation exercises.

Interventions

high frequency (10 HZ) rTMS pulses are applied to the dorsolateral prefrontal cortex of the dominant hemisphere.

Group A (r TMS group)

galvanic stimulation of the vestibular apparatus

Group B (Galvanic stimulation)

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Definite diagnosis with unilateral peripheral vestibular disorders from audiologist or neurologist.
  • The patient's age will be ranged from thirty to sixty years old.
  • Patients will experience at least two symptoms of common symptoms of peripheral vestibular disorders.
  • Symptoms of vertigo and nystagmus lasting from seconds to one minute.
  • Vertigo that arises from changes in head position related to gravity.
  • Patients who experienced symptoms for more than three months (chronic patients)
  • Patients were selected to be ambulant.
  • Patients suffer from balance disturbance with low risk falling (41-56) and moderate risk falling ranges (21-40) according to berg balance scale.
  • All patients were medically stable, controlled with medical drugs for at least three months and failed to medical treatment with no other physical, mental or cognitive disorders.

You may not qualify if:

  • Benign positional vertigo.
  • Central vestibular disorders ( Ms, ataxia, migraine headache, posterior inferior cerebellar artery syndrome "PICA").
  • Vertigo that arises from changes in head position not related to gravity; as vertigo of cervical origin or vascular origin ( Vertebro- basilar insufficiency "VBI").
  • Previous surgery of the ear.
  • Bilateral peripheral vestibular weakness, central vestibular weakness, mixed vestibular weakness, or acute vestibular weakness.
  • Unstable health issues (cardiac dysfunction, end stage renal failure, unstable diabetes, uncontrolled hypertension \>190/110…).
  • Pacemaker or other implanted electrically sensitive device.
  • Significant orthopedic or chronic pain syndrome (e.g any condition that wouldn't permit to completion of any of the tests).
  • Major cognitive dysfunction. neurodegenerative disease or major psychiatric condition ( Alzheimer's disease , depression….).
  • Chronic use of medications that could influence motor or sensory excitability (e.g AEDs, antipsychotic).
  • Alcohol abuse.
  • Epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo university

Cairo, Giza Governorate, 12613, Egypt

RECRUITING

MeSH Terms

Interventions

Transcranial Magnetic Stimulation

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Central Study Contacts

Reham A.M. Ahmed, Phd

CONTACT

Hesham M. S. Nafia, M.Sc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 8, 2019

Study Start

February 1, 2019

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

February 14, 2024

Record last verified: 2024-02

Locations